Latest Advances

  • Condition: Hairy Cell Leukemia
  • Journal: Journal of hematology & oncology
  • Treatment Used: Moxetumomab Pasudotox
  • Number of Patients: 80
  • Published —
In this study, researchers evaluated the outcomes of using moxetumomab pasudotox for the treatment of relapsed/refractory hairy cell leukemia in patients who have tried other treatments.
  • Condition: Idiopathic Capillary Leak Syndrome
  • Journal: Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina)
  • Treatment Used: Extracorporeal Membrane Oxygenation
  • Number of Patients: 1
  • Published —
This case report describes a patient with idiopathic capillary leak syndrome that was treated using extracorporeal membrane oxygenation.
  • Condition: Multiple Limb Compartment Syndrome from Metformin and Vildagliptin Overdose
  • Journal: Medicine
  • Treatment Used: Decompressive Fasciotomy
  • Number of Patients: 1
  • Published —
This case report describes a patient that experienced multiple limb compartment syndrome from a metformin and vildagliptin overdose.
  • Condition: Capillary Leak Syndrome (CLS) From Rituximab Therapy of Lymphoma
  • Journal: Journal of investigative medicine high impact case reports
  • Treatment Used: Avoiding Further Rituximab Exposure
  • Number of Patients: 0
  • Published —
This case study reported on clinical manifestation, laboratory features, and radiological findings of capillary leak syndrome (CLS) from rituximab therapy when employed in combination with a multi-agent chemotherapy regimen (EPOCH-R).
  • Condition: Systemic Capillary Leak Syndrome Secondary to COVID-19
  • Journal: Chest
  • Treatment Used: Fasciotomies
  • Number of Patients: 0
  • Published —
This case report describes a patient with acute COVID-19 who developed rhabdomyolysis and compartment syndrome of all four extremities treated with fasciotomies.
  • Condition: Blastic Plasmacytoid Dendritic Cell Neoplasm
  • Journal: Expert review of anticancer therapy
  • Treatment Used: Tagraxofusp
  • Number of Patients: 0
  • Published —
This study reviewed the safety and effectiveness of tagraxofusp in adults with blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare, aggressive hematologic (blood) malignancy.
  • Condition: Blastic Plasmacytoid Dendritic Cell Neoplasm
  • Journal: Hematology/oncology clinics of North America
  • Treatment Used: Tagraxofusp
  • Number of Patients: 1
  • Published —
This study tested the safety and efficacy of using tagraxofusp to treat patients with blastic plasmacytoid dendritic cell neoplasm.
  • Condition: Systemic Sclerosis
  • Journal: The Israel Medical Association journal : IMAJ
  • Treatment Used: Autologous Hematological Stem Cell Transplant
  • Number of Patients: 5
  • Published —
This study tested the safety and efficacy of using autologous hematological stem cell transplantation to treat patients with systemic sclerosis.
  • Condition: Relapsed or Refractory Childhood B-Lineage Acute Lymphoblastic Leukemia
  • Journal: Pediatric blood & cancer
  • Treatment Used: Moxetumomab Pasudotox
  • Number of Patients: 32
  • Published —
This study tested the safety and efficacy of using moxetumomab pasudotox to treat patients with relapsed or refractory childhood B-lineage acute lymphoblastic leukemia.
  • Condition: Vincristine-induced systemic capillary leak syndrome in patients with Wilm's tumor
  • Journal: Pediatric hematology and oncology
  • Treatment Used: Steroid therapy
  • Number of Patients: 7
  • Published —
The study researched the outcomes of unexpected vincristine-induced systemic capillary leak syndrome in patients with Wilm's tumor.
  • Condition: Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
  • Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
  • Treatment Used: Tagraxofusp-erzs
  • Number of Patients: 13
  • Published —
This study evaluated tagraxofusp-erzs for the treatment of blastic plasmacytoid dendritic cell neoplasms (BPDCN) in adult and pediatric patients 2 years and older.
  • Condition: Hemophagocytic lymphohistiocytosis with capillary leak syndrome (CLS).
  • Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
  • Treatment Used: Reasonable fluid replacement and oxygen supply
  • Number of Patients: 66
  • Published —
The aim of the study was to investigate the characteristics of secondary hemophagocytic lymphohistiocytosis (sHLH) with capillary leak syndrome (CLS).
Showing 1-12 of 17